Viraj Shah

Mr. Viraj Shah

Medicine, Imperial College London, London, City of London, UK
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2022 in Medical Teacher
Verified
Journal Article
Open access
JBJames Bevan
James Bevan
RBRachel Blyth
Rachel Blyth
BRBenjamin Russell
Benjamin Russell
LHLydia ML Holtgrewe
Lydia ML Holtgrewe
ACAnnie Hoi Ching Cheung
Annie Hoi Ching Cheung
SFSimon Fraser
Simon Fraser
The doctors of the future need to be empowered to deliver healthcare sustainably while protecting their patients' health in the context of a degrading environment. This study aimed to objectively review the extent and nature of the teaching of planetary health and sustainability topics in UK medical education. A multi-centre national review of the timetabled teaching sessions in medical courses in the UK during the academic year 2020/2021 against the General Medical Council's adopted 'Educating for Sustainable Healthcare - Priority Learning Outcomes'. Medical students were recruited and reviewed the entirety of their own institution's online teaching materials associated with core teaching sessions using a standardised data collection tool. Learning outcome coverage and estimated teaching time were calculated and used to rank participating medical schools. 45% of eligible UK medical schools were included in the study. The extent of teaching varied considerably amongst courses. Mean coverage of the 13 learning outcomes was 9.9 (SD:2.5) with a mean estimated teaching time of 140 min (SD:139). Courses with dedicated planetary health and sustainability sessions ranked best. There is large disparity in the education that medical students receive on these topics. Teaching may not adequately prioritise sustainability or reflect advances in planetary health knowledge.[Box: see text].

7 August 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JBJack Barton
Jack Barton
AWAnna Wozniak
Anna Wozniak
CSChloe Scott
Chloe Scott
ACAbhisekh Chatterjee
Abhisekh Chatterjee
GTGreg Nathan Titterton
Greg Nathan Titterton
JKJuan Carlos Kaski
Juan Carlos Kaski
Between-sex differences in the presentation, risk factors, management, and outcomes of acute myocardial infarction (MI) are well documented. However, as such differences are highly sensitive to cultural and social changes, there is a need to continuously re-evaluate the evidence. The present contemporary systematic review assesses the baseline characteristics of men and women presenting to secondary, tertiary, and quaternary centres with acute myocardial infarction (MI). Over 1.4 million participants from 18 studies, including primary prospective, cross sectional and retrospective observational studies, as well as secondary analysis of registry data are included in the study. The study showed that women were more likely than men to have a previous diagnosis of diabetes, hypertension, cerebrovascular disease, and heart failure. They also had lower odds of presenting with previous ischaemic heart disease and angina, dyslipidaemia, or a smoking history. Further work is necessary to understand the reasons for these differences, and the role that gender-specific risk factors may have in this context. Moreover, how these between-gender differences are implicated in management and outcomes also requires further work.

1 August 2023
Verified
Book Chapter
Closed access
PDF file
ARArian Arjomandi Rad
Arian Arjomandi Rad
HPHariharan Subbiah Ponniah
Hariharan Subbiah Ponniah
VSViraj Shah
Viraj Shah
SNSukanya Nanchahal
Sukanya Nanchahal
RVRobert Vardanyan
Robert Vardanyan
JMJohann Malawana
Johann Malawana

Verified
Journal Article
Open access
PDF file
VSViraj Shah
Viraj Shah
BHBashar Hassan
Bashar Hassan
RHRena Hassan
Rena Hassan
MAMalory Alexis
Malory Alexis
MBMyan Bhoopalam
Myan Bhoopalam
FLFan Liang
Fan Liang
Objectives: Fewer than one-fifth of all studies on gender-affirming care originate from low- and middle-income countries (LMICs). This is the first systematic review to examine surgical demographics and outcomes following gender-affirming surgery (GAS) in LMICs. Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, five databases were systematically searched for original studies and case series on GAS within LMIC settings. Excluded reports included animal studies, non-English language studies, secondary studies including reviews, individual case reports and conference abstracts. Results: This review includes 34 studies involving n = 5064 TGNB individuals. Most studies (22, 64.7%) were from upper-middle-income countries, followed by lower-middle-income countries (12, 35.3%). A total of 31 studies (91.2%) reported on post-operative outcomes. Of n = 5013 patients who underwent GAS, 71.5% (n = 3584) underwent masculinizing and 29.5% (n = 1480) underwent feminizing procedures. The predominant procedures were metoidioplasty (n = 2270/3584, 63.3%) and vaginoplasty (n = 1103/1480, 74.5%). Mean follow-up was 47.7 months. In patients who underwent metoidioplasty, 6.8% (n = 155) of patients experienced a complication and 6.3% (n = 144) underwent revision surgery. In patients who underwent vaginoplasty, 11.5% (n = 127) of patients experienced a complication and 8.5% (n = 94) underwent revision surgery. Of the studies (25/34, 73.5%) that reported on quality of life and post-operative satisfaction, the majority showed marked improvements in psychosocial and functional outcomes. Notably, no post-surgical regret was reported among the surveyed patients. Conclusions: Existing literature on GAS in LMICs remains scarce and is concentrated in select institutions that drive specific procedures. Our review highlights the low reported volumes of GAS, variability in surgical outcomes and quality of life.

22 April 2023 in Artificial Organs
Verified
Journal Article
Open access
Arian Arjomandi RadArian Arjomandi Rad
Arian Arjomandi Rad
AZAlina Zubarevich
Alina Zubarevich
VSViraj Shah
Viraj Shah
OYOgulcan Yilmaz
Ogulcan Yilmaz
RVRobert Vardanyan
Robert Vardanyan
AWAlexander Weymann
Alexander Weymann
Background: Left ventricular assist devices (LVADs) represent an important therapeutic option for patients progressing to end‐stage heart failure. LVAD has previously been shown to have a promising role in improving mitral regurgitation (MR). Nevertheless, the prognostic value of preoperative uncorrected MR in this population remains unclear. Methods: A systematic database search with meta‐analysis was conducted of comparative original articles of patients with preoperative mild MR (Grade 0–I) versus moderate–severe MR (Grade II–III) undergoing LVAD implantation, in EMBASE, MEDLINE, Cochrane database, and Google Scholar, from inception to June 2022. Primary outcomes were overall and operative mortality. Secondary outcomes were neurological dysfunction, gastrointestinal bleeding, right heart failure, LVAD thrombosis, and driveline infection. Results: Our search yielded 2228 relevant studies. A total of 19 studies met the inclusion criteria with a total of 11 873 patients. LVAD caused a statistically significant decrease of 35.9% in the number of patients with moderate–severe MR (grade II–III) postoperatively. No significant difference was observed in terms of overall mortality, operative mortality, GI bleeding, LVAD thrombosis, and driveline infection rates between mild and moderate–severe MR. An increased rate of right heart failure was seen among patients with moderate–severe MR, while lower rates of neurological events were also observed. Conclusion: LVAD improves the haemodynamics of the left ventricle, to promote resolution of MR. Nevertheless, the severity of preoperative mitral regurgitation in patients undergoing LVAD deployment does not seem to affect mortality.

14 December 2023 in medRxiv
Verified
Preprint
Open access
PDF file
SBSanjay Budhdeo
Sanjay Budhdeo
JZJoe Zhang
Joe Zhang
YAYusuf Abdulle
Yusuf Abdulle
PAPaul M Agapow
Paul M Agapow
DMDouglas GJ McKechnie
Douglas GJ McKechnie
NSNikhil Sharma
Nikhil Sharma
Introduction: There is increasing use of knowledge graphs within medicine and healthcare, but a comprehensive survey of their applications in biomedical and healthcare sciences is lacking. Our primary aim is to systematically describe knowledge graph use cases, data characteristics, and research attributes in the academic literature. Our secondary objective is to assess the extent of real-world validation of findings from knowledge graph analysis. Methods: We conducted this review in accordance with the PRISMA extension for Scoping Reviews to characterize biomedical and healthcare uses of knowledge graphs. Using keyword-based searches, relevant publications and preprints were identified from MEDLINE, EMBASE, medRxiv, arXiv, and bioRxiv databases. A final set of 255 articles were included in the analysis. Results: Although medical science insights and drug repurposing are the most common uses, there is a broad range of knowledge graph use cases. General graphs are more common than graphs specific to disease areas. Knowledge graphs are heterogenous in size with median node numbers 46 983 (IQR 6 415-460 948) and median edge numbers 906 737 (IQR 66 272-9 894 909). DrugBank is the most frequently used data source, cited in 46 manuscripts. Analysing node and edge classes within the graphs suggests delineation into two broad groups: biomedical and clinical. Querying is the most common analytic technique in the literature; however, more advanced machine learning techniques are often used. Discussion: The variation in use case and disease area focus identifies areas of opportunity for knowledge graphs. There is diversity of graph construction and validation methods. Translation of knowledge graphs into clinical practice remains a challenge. Critically assessing the success of deploying insights derived from graphs will help determine the best practice in this area.